Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer

Lignende værker

• Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker
  af: He, Bingxi, et al.
  Udgivet: (2020)
• Tumor mutation burden in lung cancer: a new predictive biomarker for immunotherapy or too soon to tell?
  af: Alexander, Mariam, et al.
  Udgivet: (2018)
• Tumor Mutation Burden as a Biomarker in Resected Non–Small-Cell Lung Cancer
  af: Devarakonda, Siddhartha, et al.
  Udgivet: (2018)
• Tumor Mutational Burden (TMB) as a Predictive Biomarker in Solid Tumors
  af: Sha, Dan, et al.
  Udgivet: (2020)
• Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non‐Small Cell Lung Cancer
  af: Chae, Young Kwang, et al.
  Udgivet: (2019)